Navigation path


Public Health (29-01-2014)

Public consultation on the Preliminary Opinion on The safety of the use of bisphenol A in medical devices

Today, the European Commission and its non-food Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), launch a public consultation on the preliminary opinion on "The safety of the use of bisphenol A in medical devices".

The consultation will run until 26 March 2014. Interested parties are invited to provide comments on the scientific evidence underpinning this preliminary opinion online.

This opinion aims to assess whether the use of bisphenol A (BPA) in medical devices could cause any health concerns. If possible, it will also provide indications on safe limits of BPA release from medical devices. The opinion also seeks to identify whether any particular BPA-containing medical device could result in human exposures giving cause for concern within normal usage patterns. Other foreseeable circumstances (e.g. high release of BPA due to the nature of the material of the medical device or particular contact conditions) will be explored any particular risk groups, e.g. infants, pregnant and breastfeeding women, identified.

For more information on the work of the Commission's independent scientific committees: